A Computational Model-Enhanced Approach for Tumor Localization During Lumpectomy
A Computational Model-Enhanced Approach for Tumor Localization During Lumpectomy
批准号:
9306843
负责人:
INGRID M MESZOELY
金额:
$18.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2019-04-30
关键词:
AddressAlgorithmsAnatomyBiological MarkersBiomechanicsBreastBreast DiseasesBreast-Conserving SurgeryCancerous breastComplexComputer SimulationCuesCustomDataDetectionDevicesDiagnosticDiagnostic ImagingDiseaseEligibility DeterminationEncapsulatedExcisionFinancial compensationImageImaging TechniquesImaging technologyInterventionInvestmentsLasersLesionLightLiteratureLocationMagnetic ResonanceMagnetic Resonance ImagingMalignant NeoplasmsMammary Gland ParenchymaMastectomyMeasuresMethodsModelingNational Surgical Adjuvant Breast and Bowel ProjectNatureOperating RoomsOperative Surgical ProceduresOpticsPathologyPathology ReportPatientsProceduresRadiationRadiation therapyRadical MastectomyRadiology SpecialtyRecurrenceReportingResectedRetrievalRiskScanningSimple mastectomySupinationSurgeonSurgical marginsSurvival RateSystemTechniquesTechnologyTestingUltrasonographyUncertaintyUnited StatesWomanWorkbasebiomechanical modelbreast lumpectomycontrast enhancedexperienceimaging biomarkerimaging detectionimaging probeimaging studyimprovedimproved outcomeintraoperative imagingmalignant breast neoplasmnoveloperationoptical imagingpatient populationphotonicspublic health relevancesoft tissuestemtrendtumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Over the past several decades, it has been shown that breast lumpectomy is as effective as mastectomy (total or radical) when clear margins are achieved, i.e. no cancer is evident in the margins as encapsulated cancerous breast tissue is resected. Specifically, clear margins have a 5-year recurrence rate of approximately 2-7% (the same as the more radical procedures) while that risk increases to as much as 22% if positive resection margins are present. The difficulty with determining surgical margins intraoperatively, i.e. tumor localization, is that geometric and spatial cues are quickly lost in the OR presentation
which differs considerably from the pendant presentation for most diagnostic imaging studies. Generating surgical technologies that could improve the fidelity of resection would have dramatic impact to this considerable population of patients (nearly 230,000 women per year in the United States alone with 80% being detected at stages 0, 1, or 2) especially when considering recurrence rates. The combination of biomechanical computational models of soft tissue deformation with intraoperative guidance and imaging technologies to create interactive displays to help navigate and localize the tumor would be an important step forward in improving the outcomes of lumpectomy. Our hypothesis in this application is that tumor localization is a major confounding factor for improving MR-driven resections as well other complementary disease detection methods (e.g. radioguided probes, optical imaging technologies, etc.). The specific aims of the application are: (1) generate a platform technology with accompanying computational model-enhanced approach to align preoperative MR imaging data to the surgical field for conducting BCS, and (2) acquire feasibility data using two bystander
patient studies (n=6 each) measuring the extent and nature of breast deformations and assess initial model-enhanced registration framework.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Toward quantitative quasistatic elastography with a gravity-induced deformation source for image-guided breast surgery.
面向图像引导乳房手术的具有重力引起变形源的定量准静态弹性成像。
DOI:
10.1117/1.jmi.5.1.015003
发表时间:
2018
期刊:
Journal of medical imaging (Bellingham, Wash.)
影响因子:
--
作者:
[Griesenauer,RebekahH, Weis,JaredA, Arlinghaus,LoriR, Meszoely,IngridM, Miga,MichaelI]
通讯作者:
Miga,MichaelI
DOI:
10.1088/1361-6560/aa700a
发表时间:
2017-06-21
期刊:
Physics in medicine and biology
影响因子:
3.5
作者:
[Griesenauer RH, Weis JA, Arlinghaus LR, Meszoely IM, Miga MI]
通讯作者:
Miga MI
DPC4 REPLACEMENT GENE THERAPY IN PANCREATIC CANCER
-
批准号:2517831
-
项目类别:
-
资助金额:$3.41万
-
财政年份:1999
-
负责人:INGRID M MESZOELY
-
依托单位:
DPC4 REPLACEMENT GENE THERAPY IN PANCREATIC CANCER
-
批准号:6077882
-
项目类别:
-
资助金额:$3.35万
-
财政年份:1998
-
负责人:INGRID M MESZOELY
-
依托单位:
海外基金